Please login to the form below

Not currently logged in
Email:
Password:

Axentis Pharma takes over cystic fibrosis patents

Swiss biotech company Axentis Pharma has taken over Austrian-based BioDevelops Pharma, acquiring the rights to key cystic fibrosis screening patents.
Swiss biotech company Axentis Pharma has taken over Austrian-based BioDevelops Pharma, acquiring the rights to key cystic fibrosis screening patents.

Three years ago, the Austrian company identified a new approach to treating cystic fibrosis; targeting the process through which the body destroys its own proteins - the direct cause of cystic fibrosis. The patents also cover the second medical use of Velcade in cystic fibrosis.

Joerg Zielasek, president of Axentis Pharma said: "By acquiring the rights to BioDevelops' technology platform, Axentis Pharma is both enhancing its development pipeline and offering patients and investors extensive prospects for the treatment of this disease."

Cystic fibrosis is a hereditary disease caused by a mutation in the CFTR gene found on chromosome 7. The mutation causes increased secretion deposits on mucous membranes. These deposits lead to lung complications that in turn result in high mortality rates among sufferers.

26th June 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Beyond the event
...
Anthill Agency and Actando partnership to Transform Pharma's Digital Skills
Anthill Agency, a leading life sciences digital agency, today announced the launch of the Anthill Academy™ and partnership with Actando's PharmAcademy....
Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...

Infographics